Hertfordshire, United Kingdom

Beatriz Goyenechea Corzo

USPTO Granted Patents = 19 

 

Average Co-Inventor Count = 8.3

ph-index = 3

Forward Citations = 32(Granted Patents)


Location History:

  • Stevenage, GB (2022 - 2023)
  • Hertfordshire, GB (2020 - 2024)

Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Exploring the Contributions of Beatriz Goyenechea Corzo

Introduction

Beatriz Goyenechea Corzo is an influential innovator based in Hertfordshire, Great Britain. With a remarkable portfolio that includes 19 patents, she has made significant strides in the field of biotechnology, particularly in the development of antibody agents for medical applications.

Latest Patents

Among her latest patents, Goyenechea Corzo has developed groundbreaking CD38 modulating antibody agents. These patents provide antibody sequences that specifically bind to human CD38, offering a foundation for fully human monoclonal antibodies and antigen-binding fragments. Such advancements hold promise for medical methods and compositions, especially in the treatment of cancer, showcasing her commitment to enhancing pharmaceutical manufacturing and development.

Career Highlights

Goyenechea Corzo has garnered experience working with reputable organizations such as Tusk Therapeutics Ltd. and Cancer Research Technology Limited. Her work in these companies has contributed to crucial advancements in therapeutic antibody development and cancer research, establishing her reputation as a leading inventor in her field.

Collaborations

Throughout her career, Goyenechea Corzo has collaborated with esteemed professionals such as Anne Goubier and Josephine Salimu. These partnerships have enabled the fusion of ideas and expertise, further driving innovation in the biotechnological landscape.

Conclusion

Beatriz Goyenechea Corzo exemplifies the spirit of innovation in the biopharmaceutical sector. Her work on CD38 modulating antibody agents not only highlights her inventive prowess but also underscores the potential of her contributions to transforming cancer treatment through advanced therapeutic solutions. Her continued dedication to research and development solidifies her position as a pivotal figure in the world of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…